MIS Report Submission Deadline: March 15,
Submit via DOT DAMIS at https://damis.dot.gov — MFA via Login.gov required.
Authority: 14 CFR §§ 120.119(a) and 120.219(b) | 49 CFR § 40.26
Section III — Drug Testing Data Click any cell to edit · Yellow = manual override
Auto-populated from test records for selected year. Click a cell to override.
Test Category Total Tests (excl. cancelled/blind) Verified Negative Verified Positive Positive THC/Marijuana Positive Cocaine Positive PCP Positive Opiates Positive Amphetamines Refusal — Adulterated Refusal — Substituted Refusal — Shy Bladder Refusal — Other Cancelled
Loading...
Section IV — Alcohol Testing Data Click any cell to edit · Yellow = manual override
Auto-populated from test records for selected year. Click a cell to override.
Test Category Total Screening Tests Screening Results < 0.02 Screening Results ≥ 0.02 Total Confirmation Tests Confirmation Results 0.02–0.039 Confirmation Results ≥ 0.04 Refusal — Shy Lung Other Refusals Cancelled
Loading...
Lab Statistical Summaries 49 CFR 40.111 · Medtox and CRL send these twice a year
Loading...
Company Profile Required for MIS
Certifying Official
C/TPA (Optional)
Section II — Covered Employees
Total in Random Pool
0
Active employees only
as of Dec 31 of report year
Loading...
Submission Checklist 0/7 complete
SAP Return-to-Duty Documentation
An employee must remain removed from all DOT/FAA safety-sensitive functions until the SAP process is completed, the employer receives the SAP's written successful-compliance report, and the employee completes the required return-to-duty test with an acceptable result.
Required Sequence
1RemoveImmediately remove the employee from DOT/FAA safety-sensitive functions.
2Initial evaluationThe SAP evaluates the employee and sends the written initial report directly to the DER.
3Education / treatmentThe employee completes the SAP's recommendations and any required continuing-care steps.
4Follow-up evaluationThe SAP sends the written determination directly to the DER.
5Return-to-duty testOnly after successful compliance is documented may the employer arrange the return-to-duty test.
6Follow-up testingAll SAP-directed follow-up tests must be completed if the employee returns to safety-sensitive duty.
1 — SAP Initial Evaluation Report

Signed, dated report on the SAP's letterhead sent directly to the DER. Must contain:

  1. Employee's name and SSN or employee ID;
  2. Employer's name and address;
  3. Reason for assessment, DOT violation and date;
  4. Date(s) and format of assessment (face-to-face or remote);
  5. SAP's specific education and/or treatment recommendation;
  6. SAP's telephone number.

Ref: 49 CFR 40.293, 40.311(c)

2 — SAP Follow-Up Evaluation Report

When successful compliance is determined:

  1. Employee's name and SSN or employee ID;
  2. Employer's name and address;
  3. Reason for initial assessment, DOT violation and date;
  4. Dates and format of initial assessment + synopsis of treatment plan;
  5. Name of each provider that delivered education and/or treatment;
  6. Inclusive dates of the employee's participation;
  7. Clinical characterization of program participation;
  8. SAP's clinical determination of successful compliance;
  9. Written follow-up testing plan;
  10. Continuing-care needs;
  11. SAP's telephone number.

When successful compliance is NOT demonstrated:

SAP sends written notice directly to the DER. Employee must not be returned to safety-sensitive duties. Report must contain items 1–7 above plus:

  1. Date(s) of first follow-up evaluation;
  2. Date(s) of any additional follow-up evaluations;
  3. SAP's clinical reasons for non-compliance determination;
  4. SAP's telephone number.

Ref: 49 CFR 40.301, 40.311(d)–(e)

3 — Follow-Up Testing Plan
  • SAP is the sole determiner of number, frequency, and type (drug/alcohol/both).
  • Minimum 6 unannounced tests in the first 12 months of return.
  • SAP may require additional testing for up to 48 more months.
  • Employer selects dates — no discernible pattern allowed.
  • Random tests cannot substitute for required follow-up tests.
  • A cancelled follow-up test does not count; it must be recollected.
  • Requirement follows the employee through employer changes or breaks in service.
Confidential: The employee must not receive a copy of the follow-up testing schedule and must not be told its frequency or duration.

Ref: 49 CFR 40.307, 40.309

4 — Requirements Before Return to Safety-Sensitive Duty
  • DER must receive the SAP's written successful-compliance report and follow-up testing plan.
  • Return-to-duty test cannot occur until SAP confirms successful compliance.
  • The employer — not the SAP — directs the return-to-duty test.
  • Drug violation: return-to-duty drug test under direct observation, negative result required.
  • Alcohol violation: return-to-duty alcohol test with result below 0.02.
  • Do not confuse return-to-duty test with the SAP's follow-up testing plan.
  • Meeting regulatory conditions makes the employee eligible — it does not require reinstatement.

When return-to-duty drug test may also satisfy pre-employment:

  • CCF must be annotated or a statement attached explaining the dual purpose.
  • Collection must be under direct observation when urine is used.

Ref: 49 CFR 40.289, 40.305, 40.309; 14 CFR 120.109(e)–(f), 120.217(e)–(f)

5 — Delivery and Record Retention
  • SAP must send each report directly to the DER — not through a third party.
  • SAP may simultaneously copy AMS Compliance as the employer's C/TPA.
  • Employer must receive the report directly and ensure no third party altered it.
  • Employer must retain SAP reports for 5 years from date received.
  • SAP must retain copies for 5 years.

Ref: 49 CFR 40.311(a)–(b), 40.311(g)–(h)

DER File Checklist

Use before authorizing a return-to-duty test and throughout the follow-up testing period.

Regulatory references: 49 CFR Part 40, Subpart O §§ 40.289, 40.293, 40.301, 40.305, 40.307, 40.309, 40.311; 14 CFR 120.109, 120.217